China's Birthrate Declines, Yet the Child-Care Industry Thrives.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 18 hours ago
0mins
Should l Buy TCOM?
Source: Barron's
China's Birthrate Crisis: China's declining birthrate is viewed as a significant issue, leading to fewer workers and a growing number of retirees, which could slow economic growth.
Government Response: In response to this demographic challenge, Beijing is shifting its approach by attempting to categorize the birthrate issue as a spending priority.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TCOM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TCOM
Wall Street analysts forecast TCOM stock price to rise
7 Analyst Rating
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 48.490
Low
82.00
Averages
85.00
High
90.00
Current: 48.490
Low
82.00
Averages
85.00
High
90.00
About TCOM
Trip.com Group Limited is a global travel service provider comprising Trip.com, Ctrip, Skyscanner and Qunar. Its one-stop travel platform connects its users and its ecosystem partners. It offers accommodation reservations, transportation ticketing, packaged tours, and corporate travel management services and other travel-related services to meet the various booking and traveling needs of both leisure and business travelers through its travel platform. It helps travelers around the world make informed and cost-effective bookings for travel products and services and enables partners to connect their offerings with users through the aggregation of comprehensive travel-related content and resources and an advanced transaction platform, including apps, websites and 24/7 customer service centers. Ctrip provides travel and related services in China. Qunar is an online travel agency in China. Trip.com is an online travel agency for global travelers. Skyscanner is a travel search company.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Notice: Rosen Law Firm reminds investors who purchased Trip.com (NASDAQ: TCOM) securities between April 30, 2024, and January 13, 2026, to apply as lead plaintiffs by May 11, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors joining the class action will incur no out-of-pocket expenses, as attorney fees will be covered through a contingency fee arrangement, thereby reducing financial barriers and encouraging broader participation from affected investors.
- Law Firm Background: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, showcasing its expertise and successful track record, which enhances investor confidence in their representation.
- Case Details: The lawsuit alleges that defendants made false or misleading statements and failed to disclose regulatory risks facing Trip.com, resulting in investor losses when the truth emerged, underscoring the importance of careful selection of legal counsel for investors.
See More
- Class Action Initiated: Robbins LLP reminds shareholders that a class action has been filed on behalf of investors who purchased Trip.com (NASDAQ:TCOM) American Depository Shares between April 30, 2025, and January 13, 2026, highlighting investor concerns over potential legal risks.
- Understated Regulatory Risks: The lawsuit alleges that Trip.com failed to adequately disclose the regulatory risks associated with its monopolistic business practices, resulting in materially false and misleading statements about the company's operations and prospects, which could significantly impact investor decisions.
- Stock Price Volatility: On January 14, 2026, following news of China's antitrust investigation into Trip.com, the stock price plummeted by 17.05%, or $12.90 per ADS, indicating a strong market reaction to the company's compliance issues.
- Shareholder Action Guidance: Shareholders can submit their papers by May 11, 2026, to serve as lead plaintiff in the class action, reflecting a growing emphasis on corporate governance and shareholder rights protection.
See More
- Lawsuit Background: Trip.com Group is facing a securities class action lawsuit for allegedly violating China's Anti-Monopoly Law, representing investors who purchased its securities between April 30, 2024, and January 13, 2026, highlighting serious concerns about the company's compliance.
- Stock Price Plunge: On January 14, 2026, Trip.com's American Depositary Shares plummeted by 17%, resulting in over $8 billion in market capitalization loss in a single day, reflecting investor panic over regulatory risks associated with the company.
- Regulatory Investigation: Trip.com disclosed on January 14, 2026, that it received a notice of investigation from the State Administration for Market Regulations, indicating that its AI pricing adjustment tool may have led to anti-competitive practices, raising further doubts about the sustainability of its business model.
- Executive Changes: Shortly after the class action lawsuit, Trip.com's co-founders abruptly resigned from the board on February 26, 2026, suggesting deeper governance issues within the company that could undermine investor confidence.
See More
- Class Action Notice: Robbins Geller law firm announces that investors who purchased Trip.com (NASDAQ: TCOM) securities between April 30, 2024, and January 13, 2026, can seek lead plaintiff status by May 11, 2026, highlighting investor concerns over potential legal risks facing the company.
- Details of Allegations: The lawsuit alleges that Trip.com and its executives made false statements and failed to disclose regulatory risks stemming from monopolistic practices during the class period, which could damage the company's reputation and impact future market performance.
- Antitrust Investigation Impact: On January 14, 2026, Bloomberg reported that China is investigating Trip.com for alleged antitrust conduct, stating that the company faced scrutiny for imposing unfair restrictions on merchant transactions and pricing, leading to a 19% drop in stock price over two trading sessions, reflecting market concerns about compliance.
- Investor Rights Protection: Under the Private Securities Litigation Reform Act of 1995, any investor who purchased Trip.com securities during the class period can apply to be the lead plaintiff, representing all other investors, emphasizing the importance of investor participation in legal proceedings.
See More
China's Birthrate Crisis: China's declining birthrate is viewed as a significant issue, leading to fewer workers and a growing number of retirees, which could slow economic growth.
Government Response: In response to this demographic challenge, Beijing is shifting its approach by attempting to categorize the birthrate issue as a spending priority.
See More
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Trip.com, seeking damages for investors who purchased securities between April 30, 2024, and January 13, 2026, indicating a significant loss of investor confidence in Trip.com.
- Regulatory Risks Concealed: The complaint alleges that Trip.com executives failed to disclose regulatory risks associated with their monopolistic business practices during the class period, leading to materially misleading statements about the company's operations and prospects, which could adversely affect future investment decisions.
- Investor Rights Protection: Affected investors are encouraged to apply to be lead plaintiffs by May 11, 2026, highlighting the urgency and importance of legal action to protect their rights and recover losses.
- No-Cost Representation: Bronstein, Gewirtz & Grossman, LLC offers contingency fee representation, meaning investors do not have to pay attorney fees unless they win, which may attract more affected investors to join the lawsuit.
See More











